XPNPEP3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.23234755733392E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.50849999158709E-09 |
Normal-vs-Stage2 |
1.24990000016645E-07 |
Normal-vs-Stage3 |
3.33066907387547E-16 |
Normal-vs-Stage4 |
3.73145958576515E-12 |
Stage1-vs-Stage2 |
4.248400E-01 |
Stage1-vs-Stage3 |
4.758500E-04 |
Stage1-vs-Stage4 |
1.383900E-02 |
Stage2-vs-Stage3 |
8.351600E-02 |
Stage2-vs-Stage4 |
2.508800E-01 |
Stage3-vs-Stage4 |
6.030200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62947433324234E-12 |
Normal-vs-AfricanAmerican |
2.17599999996487E-06 |
Normal-vs-Asian |
2.738600E-03 |
Caucasian-vs-AfricanAmerican |
2.514000E-01 |
Caucasian-vs-Asian |
8.841000E-01 |
AfricanAmerican-vs-Asian |
5.711000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
1.15400000000321E-07 |
Male-vs-Female |
1.639240E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.60919999547815E-08 |
Normal-vs-Age(41-60Yrs) |
1.28020039014132E-10 |
Normal-vs-Age(61-80Yrs) |
1.64035451888367E-12 |
Normal-vs-Age(81-100Yrs) |
5.72759999999395E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.890000E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.706430E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.328600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.907380E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.966400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.718200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.969630E-01 |
Normal-vs-Grade 2 |
2.44460007792213E-11 |
Normal-vs-Grade 3 |
2.52065035510896E-12 |
Normal-vs-Grade 4 |
1.64013247427874E-12 |
Grade 1-vs-Grade 2 |
5.143700E-02 |
Grade 1-vs-Grade 3 |
2.486200E-02 |
Grade 1-vs-Grade 4 |
1.304170E-03 |
Grade 2-vs-Grade 3 |
3.815600E-01 |
Grade 2-vs-Grade 4 |
4.960500E-03 |
Grade 3-vs-Grade 4 |
3.144400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.85217999999487E-05 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
7.9152018273021E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.91630053439462E-11 |
Normal-vs-N1 |
5.29469999954735E-07 |
N0-vs-N1 |
5.452500E-02 |
|
|